Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1485 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Neovacs S.A.. (3/7/16). "Press Release: Neovacs Reports Full Year 2015 Finanical Results". Paris. 2016-03-07
Poxel S.A.. (3/4/16). "Press Release: Poxel to Present at 28th Annual Roth Conference". Lyon. 2016-03-04
bioMérieux S.A.. (3/2/16). "Press Release: 2015 Financial Results". 2016-03-02
Novasep S.A.. (3/2/16). "Press Release: Novasep Presents the Second Successful Year of Its »Back to Basics« Strategy and Preliminary 2015 Financial Results". Lyon Gerland. 2016-03-02
ImaBiotech S.A.S.. (3/16). "Press Release: Imabiotech Obtain 6M€ for a New European Project in Partnership with Lille I University and Cubic Pharmaceuticals". 2016-03-01
Ipsen S.A.. (3/1/16). "Press Release: Exelixis and Ipsen Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Regions Outside the United States, Canada and Japan". Paris & South San Francisco, CA. 2016-03-01
Ipsen S.A.. (3/1/16). "Press Release: Ipsen’s 2015 Results and 2016 Financial Objectives". Paris. 2016-03-01
PeptiMimesis. (2/29/16). "Press Release: PeptiMimesis – New Biotech Startup Developing Next Generation Therapeutic Peptides in Immuno-oncology, Oncology and Immune Diseases". Strasbourg. 2016-02-29
Genfit S.A.. (2/29/16). "Press Release: Genfit Raises EUR 49.6 Million in Private Placement [Not for publication or distribution in the United States, Canada, Australia or Japan]". Lille & Boston, MA. 2016-02-29
Onxeo S.A.. (2/29/16). "Press Release: Onxeo Announces Acquisition of DNA Therapeutics and Provides Update on Validive Development Plan". Paris & Copenhagen. 2016-02-29
Onxeo S.A.. (2/26/16). "Press Release: Onxeo Reports 2015 Full-Year Results and Provides Business Update". Paris & Copenhagen. 2016-02-26
Nanobiotix S.A.. (2/26/16). "Press Release: Nanobiotix 2015 Q4 and Annual Revenues". Paris. 2016-02-26
Servier. (2/26/16). "Press Release: Servier Receives Positive CHMP Opinion for LONSURF (trifluridine/tipiracil) for Refractory Metastatic Colorectal Cancer". Suresnes. 2016-02-26
OSE Pharma S.A.. (2/24/16). "Press Release: OSE Pharma and Effimune Announce Proposed Merger to Create Significant Immunotherapy Player". Paris & Nantes. 2016-02-24
Valneva S.E.. (2/24/16). "Press Release: Valneva Posts 96% Revenue Growth in 2015, Forecasts 2016 Revenues of €90 to €100 Million". Lyon. 2016-02-24
Pierre Fabre S.A.. (2/22/16). "Press Release: Plasticell and Pierre Fabre Laboratories Sign a Partnership to Identify Natural Stimulants of Brown Fat for Treatment and Prevention of Obesity and Diabetes". Stevenage & Castres. 2016-02-22
LFB S.A.. (2/22/16). "Press Release: Registration of FibCLOT, LFB’s Human Fibrinogen, in Europe". Les Ulis. 2016-02-22
Pharnext S.A.S.. (2/22/16). "Press Release: Pharnext Announces the Appointment of Niall Murphy as Chief Scientific Officer and Pierre Schwich as Chief Financial Officer". Paris. 2016-02-22
Onxeo S.A.. (2/22/16). "Press Release: Onxeo Expands Collaborations to Advance Development Program of Key Orphan Oncology Assets in Combination with Immuno-oncology Agents". Paris & Copenhagen. 2016-02-22
OSE Pharma S.A.. (2/22/16). "Press Release: First Patients Enrolled and Dosed in the Pivotal Trial of Phase 3 of the Immunotherapy Tedopi for Advanced Non-small Cell Lung Cancer". Paris. 2016-02-22
Cellnovo. (2/22/16). "Press Release: Cellnovo Appoints Thierry Moulin as Chief Financial Officer". Paris. 2016-02-22
Pherecydes Pharma S.A.. (2/22/16). "Press Release: Antibiotic resistance. Pherecydes Pharma Appoints Guy-Charles Fanneau de La Horie as Chief Executive Officer". Romainville. 2016-02-22
Onxeo S.A.. (2/17/16). "Press Release: Onxeo to Attend Upcoming Investor Conferences and Medical Meetings". Paris & Copenhagen. 2016-02-17
Ipsen S.A.. (2/17/16). "Press Release: Ipsen Enters into a Licensing Agreement with 3B Pharmaceuticals to Develop Novel Radiopharmaceuticals in Oncology". Paris. 2016-02-16
Servier. (2/12/16). "Press Release: EMA Benefit/Risk Revision of Fusafungine-containing Medicines". 2016-02-12
MilliDrop Instruments S.A.S.. (2/11/16). "Press Release: MilliDrop Raises €1 Million from Seventure Partners’ Quadrivium 1 Seed Fund". Paris. 2016-02-11
Abivax S.A.. (2/11/16). "Press Release: Abivax to Participate in the Upcoming RBC Capital Markets 2016 Healthcare Conference in New York, and in the Credit Suisse Healthcare Conference in London". Paris. 2016-02-11
Sanofi S.A.. (2/9/16). "Press Release: Sanofi Delivered 2015 Business EPS up 8.5% on a Reported Basis and Stable at Constant Exchange Rates Consistent with Guidance". Paris. 2016-02-09
Sanofi S.A.. (2/5/16). "Press Release: Sanofi Appoints Muzammil Mansuri to Executive Committee and Executive Vice President, Strategy & Business Development". Paris. 2016-02-05
Dassault Systèmes S.A.. (2/4/16). "Press Release: Dassault Systèmes Reports Strong Fourth Quarter Software Revenue Growth on Acceleration of 3DEXPERIENCE Adoption". Vélizy-Villacoublay. 2016-02-04
Enyo Pharma S.A.S.. (2/3/16). "Press Release: Enyo Pharma Announces Closing of a €22 Million Funding Round". 2016-02-03
Sophia Genetics S.A.. (2/2/16). "Press Release: The Paoli-Calmettes Institute (IPC) in Marseille Becomes the First Next Generation Sequencing Lab Certified in France for the Molecular Diagnosis, Thanks to a New Collaboration with Sophia Genetics". Lausan 2016-02-02
i2a S.A.. (1/28/16). "Press Release: Testing on Antimicrobial Resistance – i2a". 2016-01-28
Poxel S.A.. (1/28/16). "Press Release: Poxel Provides YE15 Cash and Turnover Figures". Lyon. 2016-01-28
Genticel S.A.. (1/27/16). "Press Release: Genticel Reports Initial Results at 12 Months from Phase 2 Trial of HPV Immunoterapeutic Candidate, GTL0001". Paris & Toulouse. 2016-01-27
Pharnext S.A.S.. (1/26/16). "Press Release: Pharnext Collaborates with OrphanDev in Europe for Its Phase 3 Clinical Trial PLEO-CMT in Charcot-Marie Tooth Type 1A Disease (CMT 1A)". Paris. 2016-01-26
Amatsigroup. (1/25/16). "Press Release: Amatsigroup Acquires Q-Biologicals and Strengthens Its Offering for International Pharmaceutical Groups". Toulouse. 2016-01-25
Onxeo S.A.. (1/25/16). "Press Release: Onxeo Announces the Evolution and Reinforcement of Its Board of Directors". Paris & Copenhagen. 2016-01-25
Genticel S.A.. (1/25/16). "Press Release: Business Update – Fourth Quarter 2015". Paris & Toulouse. 2016-01-25
Eurofins. (1/22/16). "Press Release: Biomnis, in Partnership with ODPM, Launches a Test to Determine the Toxicity Risk of Widely-used Chemotherapy". 2016-01-22
Neovacs S.A.. (1/21/16). "Press Release: Neovacs Associates Stellar Biotechnologies in Its Industrial Project". Paris & Boston, MA. 2016-01-21
Toulouse White Biotech (TWB). (1/19/16). "Press Release: TWB and AMOEBA – Towards the Industrialization of a Revolutionary Biological Biocide against Legionella". Toulouse. 2016-01-19
Genomic Vision S.A.. (1/18/16). "Press Release: 2015 Sales in Line with Expectations After All Planned Milestones with Quest Diagnostics Were Met". Bagneux. 2016-01-18
Novasep S.A.. (1/13/16). "Press Release: Novasep and Advanced Biotherapeutics Consulting Team Up on Adeno-associated Virus (AAV) Vectors". Pompey & Lyon. 2016-01-13
Sanofi S.A.. (1/11/16). "Press Release: Sanofi and Innate Pharma Collaborate on New Bispecific NK Cell Engagers in Immuno-Oncology". Paris & Marseille. 2016-01-11
Sanofi S.A.. (1/11/16). "Press Release: Sanofi and Warp Drive Bio to Collaborate on the Development of Novel Oncology Therapies and Antibiotics Based on Proprietary Platforms". Paris & Marseille. 2016-01-11
Genomic Vision S.A.. (1/11/16). "Press Release: Genomic Vision Expands Its Senior Management Team through a Number of Strategic Recruitments". Bagneux. 2016-01-11
Innate Pharma S.A.. (1/10/16). "Press Release: Innate Pharma In-licenses Orega Biotech's First-in-class anti-CD39 Checkpoint Inhibitor Program". Marseille & Lyon. 2016-01-10
Sanofi S.A.. (1/8/16). "Press Release: Sanofi and Regeneron Announce Sarilumab Biologics License Application Accepted for Review by US FDA". Paris & Tarrytown, NY. 2016-01-08
Enterome Bioscience S.A.. (1/7/16). "Press Release: Enterome Announces Collaboration with Johnson & Johnson Innovation Focused on the Discovery of Novel Targets and Therapeutics for Crohn’s Disease". Paris & Boston, MA. 2016-01-07
Evotec AG. (1/7/16). "Press Release: Evotec and UCB Sign Multi-year Sample Management Agreement". Hamburg. 2016-01-07
Carbios S.A.. (1/7/16). "Press Release: Report on Carbios’ Liquidity Contract with Invest Securities". Clermont-Ferrand. 2016-01-07
Genticel S.A.. (1/7/16). "Press Release: Genticel to Evaluate Roche Molecular Systems’ cobas HPV Test in Preparation for Phase 3 Porgram of GTL001". Paris & Toulouse. 2016-01-07
Neovacs S.A.. (1/6/16). "Press Release: Neovacs Secures €5 Million from the Public Funding Program »Investments for the Future« to Support Clinical and Industrial Development for the Therapeutic Vaccine INFa Kinoïd". Paris & Boston, MA. 2016-01-06
bioMérieux S.A.. (1/5/16). "Press Release: bioMérieux Acquires Applied Maths and Enhances Its Bioinformatics Capabilities with Cutting-edge Expertise and Solutions for the Smart Use of Complex Biological Data". Marcy l’Étoile. 2016-01-05
Innate Pharma S.A.. (1/5/16). "Press Release: Upcoming Investor Conferences". 2016-01-05
OSE Pharma S.A.. (1/5/16). "Press Release: OSE Pharma Announces Its Events for Q1 2016". Paris. 2016-01-05
Genticel S.A.. (1/5/16). "Press Release: Genticel Appoints Rémi Palmantier, PhD, as Chief Scientific Officer to Accelerate Its Development". Paris & Toulouse. 2016-01-05
Cellectis S.A.. (12/23/15). "Press Release: Cellectis Files First Clinical Trial Application for UCART19, an Allogeneic Gene Edited CAR T-Cell Product for Hematological Malignancies". New York. 2015-12-23
Cellectis S.A.. (12/21/15). "Press Release: Cellectis Announces Presentation at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco, January 11 - 14, 2016". New York. 2015-12-21
Servier. (12/18/15). "Press Release: GeNeuro Announces the Launch of Phase IIb Proof-of-Concept Study with GNbAC1 in Multiple Sclerosis and Servier Equity Investment". Geneva & Suresnes. 2015-12-18
LFB S.A.. (12/15/15). "Press Release: Doubling of Capacity at Ales Facility (LFB Biomanufacturing)". Les Ulis. 2015-12-15
GamaMabs Pharma S.A.. (12/15/15). "Press Release: GamaMabs Pharma Raises €15m in Series B Financing Round". Toulouse & Paris. 2015-12-15
Neovacs S.A.. (12/15/15). "Press Release: Neovacs Signs a Strategic Partnering Agreement with the Korean Company CKD Pharmaceutical Corp.". Paris & Boston, MA. 2015-12-15
Pierre Fabre S.A.. (12/14/15). "Press Release: Pierre Fabre and Cordeliers Research Centre Sign Strategic Partnership to Identify New Therapeutic Targets in Immuno-oncology". Castres. 2015-12-14
Seventure Partners. (12/14/15). "Press Release: A Major Pharmaceutical Company Participates as Strategic Investor in Health for Life Capital, the First Investment Vehicle Focused on the Microbiome Health and Nutrition Revolutionary Sector". Paris. 2015-12-14
bioMérieux S.A.. (12/14/15). "Press Release: bioMérieux and Illumina Announce the Launch of bioMérieux EpiSeq, a Revolutionary Next-Generation Sequencing Service for Epidemiological Monitoring of Bacterial Infections". Marcy l’Étoile & San Diego, CA. 2015-12-14
Sofinnova Partners. (12/8/15). "Press Release: Sofinnova Partners Raises €300 Million Healthcare Fund". Paris. 2015-12-08
Servier. (12/7/15). "Press Release: Servier Announces Expansion of Collaboration for the Development and Commercialization of Anticancer Drug Candidates Targeting Apoptosis". Suresnes. 2015-12-07
Erytech Pharma. (12/7/15). "Press Release: Erytech Raises Approximately €25.4 Million in a Private Placement". 2015-12-07
Eurofins Scientific. (12/3/15). "Press Release: Eurofins Expands into Hygiene Testing in Hospitals with the Acquisition of Biotech-Germande". 2015-12-03
TxCell S.A.. (12/2/15). "Press Release: TxCell Re-acquires Full Rights to Its Lead Product Ovasave. Agreement between TxCell and Trizell to Terminate the Exclusive Option". Valbonne. 2015-12-02
Carbios S.A.. (12/2/15). "Press Release: Carbios Depolymerizes 100% of PET based Plastic Waste with its Enzymatic Recycling Process. A Unique Technology Paving the Way to Infinite Recycling of PET". Clermont-Ferrand. 2015-12-02
ImaBiotech S.A.S.. (12/1/15). "Press Release: ImaBiotech’s Multimaging Technology Chosen by Dermira for Its Skin Disposition Study". Lille. 2015-12-01
MedDay Pharmaceuticals S.A.S.. (12/1/15). "Press Release: MedDay Provides Update on MS-ON Study of MD-1003". Paris. 2015-12-01
Neovacs S.A.. (12/1/15). "Press Release: Neovacs Announces Its Engagement in the Field of Immunotherapy in Cancer, Following the Recommendation of Its Scientific Advisory Board which Met in New York on the 17th of November". Paris & Boston, MA. 2015-12-01
TxCell S.A.. (11/30/15). "Press Release: TxCell Strengthens Management Team with Five New Vice Presidential Appointments". Valbonne. 2015-11-30
BioCellChallenge S.A.S.. (11/30/15). "Press Release: BioCellChallenge Obtains Unprecedented In-vivo Results Using Intracellular Delivery Technology for Therapeutic Antibodies". Toulon. 2015-11-30
Cellectis S.A.. (11/30/15). "Press Release: Cellectis Announces Presentations at Upcoming Conferences". New York. 2015-11-30
Toulouse White Biotech (TWB). (11/26/15). "Press Release: TWB Announces the Creation of EnobraQ, Specialist in CO2 Capture and Exploitation Using Yeast". Toulouse & Paris. 2015-11-26
Magnisense SE. (11/24/15). "Press Release: Magnisense Raises €5.5 Million to Better Diagnose Cardiovascular Diseases • New shareholders join the company". Paris. 2015-11-24
Ipsen S.A.. (11/19/15). "Press Release: Ipsen and Interprotein Enter into a Research Collaboration for Novel Peptides in Endocrinology". Paris & Osaka. 2015-11-19
Genfit S.A.. (11/16/15). "Press Release: Genfit Announces Pivotal Phase 3 Clinical Trial of Elafibranor in NASH Following Regulatory Input". Lille & Cambridge, MA. 2015-11-16
Catalent. (11/16/15). "Press Release: Catalent Working to Re-start Production at French Facility". 2015-11-16
Sofinnova Partners. (11/16/15). "Press Release: Sofinnova Launches BiovelocITA – the First Biotech Accelerator in Italy". Milan. 2015-11-16
Pierre Fabre S.A.. (11/16/15). "Press Release: Array BioPharma and Pierre Fabre Announce Development and Commericalization Collaboration for Two Novel Oncology Products, Binimetinib and Encorafenib". Boulder, CO. 2015-11-16
Enterome Bioscience S.A.. (11/12/15). "Press Release: Enterome and Gustave Roussy Enter into a Microbiome-based Collaboration to Develop Novel Immunotherapy Solutions to Treat Cancer". 2015-11-12
Abivax S.A.. (11/12/15). "Press Release: Abivax to Participate in the Upcoming Jefferies Global Healthcare Conference in London and the German Equity Forum in Frankfurt". Paris. 2015-11-12
ImaBiotech S.A.S.. (11/10/15). "Press Release: Galderma and ImaBiotech Develop a Long-term Alliance to Access Multimaging Services". Lille & Sophia Antipolis. 2015-11-10
Novasep S.A.. (11/10/15). "Press Release: Novasep and CPI Advance Innovation in UK Biopharmaceutical Manufacturing". Pompey. 2015-11-10
Valneva S.E.. (11/10/15). "Press Release: Valneva Reports a Strong Quarter Marked by Key Successes in its Strategic Execution and a Solid Financial Performance". Lyon. 2015-11-10
Pierre Fabre S.A.. (11/10/15). "Press Release: Pierre Fabre – a New Partner in the UNICANCER ESME Program". 2015-11-10
Pierre Fabre S.A.. (11/10/15). "Press Release: The Swiss Federal Institute of Technology in Lausanne (EPFL) and Pierre Fabre Médicament (PFM) Join Forces to Study the Use of Biosensor Chips in the Clinical Development of Drugs". Castres. 2015-11-10
Sanofi S.A.. (11/6/15). "Press Release: Sanofi Sets Out Strategic Roadmap for Long-term Growth". Paris. 2015-11-06
Sanofi S.A.. (11/6/15). "Press Release: Sanofi and Lexicon Pharmaceuticals to Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes". Paris & The Woodlands, TX. 2015-11-06
TxCell S.A.. (11/5/15). "Press Release: Financial Information for the 3rd Quarter of 2015". Valbonne. 2015-11-05
Sanofi S.A.. (11/5/15). "Press Release: Sanofi and Hanmi Announce License Agreement to Develop Portfolio of Long-acting Diabetes Treatments". Paris & Seoul. 2015-11-05
LFB S.A.. (11/5/15). "Press Release: Movements within the LFB Group". Les Ulis. 2015-11-05
bioMérieux S.A.. (11/4/15). "Press Release: bioMérieux Introduces GENE-UP, a New Molecular Diagnostic Solution for Food Pathogen Detection Jointly Developed with BioFire". Marcy l’Étoile. 2015-11-04
ElsaLys Biotech S.A.S.. (11/3/15). "Press Release: ElsaLys Biotech Announces the Completion of the First Instalment of a Total Fundraising amounting to € 5 Million". Lyon & Ilkirch-Graffenstaden. 2015-11-03
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top